Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning

C Ma, A Kuang, J Xie, T Ma - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential
throughout the patient's life after total or near-total thyroidectomy followed by 131I remnant …

Multiple signaling pathways converge on β-catenin in thyroid cancer

PH Abbosh, KP Nephew - Thyroid, 2005 - liebertpub.com
The β-catenin pathway has been conclusively demonstrated to regulate differentiation and
patterning in multiple model systems. In thyroid cancer, alterations are often seen in proteins …

Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture

E Frohlich, F Machicao, R Wahl - Endocrine-Related Cancer, 2005 - erc.bioscientifica.com
Differentiating drugs may be able to re-sensitize thyroid carcinomas to radioiodine therapy.
Substituted thiazolidinediones (TZDs) belong to the group of oral anti-diabetic drugs that …

Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer

SM Coelho, M Vaisman… - Current pharmaceutical …, 2005 - ingentaconnect.com
Although well-differentiated thyroid carcinomas are usually curable by the combined effects
of surgery, radioiodine ablation and thyroid stimulating hormone (TSH) suppressive therapy …

Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female Sprague–Dawley rats

SA Ferguson, FJ Cisneros, BJ Gough, SF Ali - Food and chemical …, 2005 - Elsevier
Despite widespread use of isotretinoin for its anti-acne effects and its current evaluation in
clinical trials as a cancer treatment, little is known about its general toxicity in adult …

[HTML][HTML] Tratamento do carcinoma diferenciado da tireóide com iodo-131: intervenções para aumentar a dose absorvida de radiação

MT Sapienza, IS Endo, GC Campos Neto… - … de Endocrinologia & …, 2005 - SciELO Brasil
OBJETIVO: Analisar medidas tomadas para aumentar a dose de radiação absorvida
(DOSE) durante o tratamento do carcinoma diferenciado da tireóide (CDT) com iodo-131 …

Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and …

G Berg, T Andersson, L Sjödell, S Jansson, E Nyström - Thyroid, 2005 - liebertpub.com
We present a case in which a patient with disseminated well-differentiated papillary thyroid
cancer developed severe thyroid-associated ophthalmopathy. Eight years after initial …

Radioiodine therapy for differentiated thyroid carcinoma: methods used to increase the radiation absorbed dose

MT Sapienza, IS Endo, GCC Neto… - Arq Bras Endocrinol …, 2005 - aem-sbem.com
OBJECTIVES: Our aim was to analyze measures taken to increase the radiation absorbed
dose (DOSE) during treatment of well-differentiated thyroid cancer (DTC) with iodine-131 …

Vitamin D3 treatment for locally advanced thyroid cancer: a case report

M Morishita, A Ohtsuru, A Kumagai, H Namba… - Endocrine …, 2005 - jstage.jst.go.jp
There are many intricacies in the surgical treatment of locally advanced thyroid cancer,
including the medical management of the remaining functional organ and any cosmetic …

Radiojodtherapie des Schilddrüsenkarzinoms

M Biermann, MK Pixberg, B Riemann, A Schuck… - Die …, 2005 - search.proquest.com
Die hoch dosierte Radiojodtherapie wird gemäß den Leitlinien der Deutschen
Krebsgesellschaft bei allen differenzierten Schilddrüsenkarzinomen zur Ablation des nach …